“Medium-term oncological outcomes of intermediate-risk prostate cancer treated with HIFU or cryotherapy. A single center 10-year experience”, Arch Ital Urol Androl, vol. 94, no. 4, pp. 413–419, Dec. 2022, doi: 10.4081/aiua.2022.4.413.